Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1989 Jun;97(2):401–408. doi: 10.1111/j.1476-5381.1989.tb11967.x

Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion.

C Thiemermann 1, G R Thomas 1, J R Vane 1
PMCID: PMC1854518  PMID: 2758223

Abstract

1. Defibrotide, a single-stranded polydeoxyribonucleotide obtained from bovine lungs, has significant anti-thrombotic, pro-fibrinolytic and prostacyclin-stimulating properties. 2. The present study was designed to evaluate the effects of defibrotide on infarct size and regional myocardial blood flow in a rabbit model of myocardial ischaemia and reperfusion. 3. Defibrotide (32 mg kg-1 bolus + 32 mg kg-1 h-1, i.v.) either with or without co-administration of indomethacin (5 mg kg-1 x 2, i.v.) was administered 5 min after occlusion of the left anterior-lateral coronary artery and continued during the 60 min occlusion and subsequent 3 h reperfusion periods. 4. Defibrotide significantly attenuated the ischaemia-induced ST-segment elevation and abolished the reperfusion-related changes (R-wave reduction and Q-wave development) in the electrocardiogram. In addition, defibrotide significantly improved myocardial blood flow in normal and in ischaemic, but not in infarcted sections of the heart. The improvement in blood flow in normal perfused myocardium, but not in the ischaemic area was prevented by indomethacin. 5. Although the area at risk was similar in all animal groups studied, defibrotide treatment resulted in a 51% reduction of infarct size. Indomethacin treatment abolished the reduction of infarct size seen with defibrotide alone. 6. The data demonstrate a considerable cardioprotective effect of defibrotide in the reperfused ischaemic rabbit myocardium. This effect may be related, at least in part, to a stimulation of endogenous prostaglandin formation. Other possible mechanisms are discussed.

Full text

PDF
401

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baller D., Bretschneider H. J., Hellige G. A critical look at currently used indirect indices of myocardial oxygen consumption. Basic Res Cardiol. 1981 Mar-Apr;76(2):163–181. doi: 10.1007/BF01907955. [DOI] [PubMed] [Google Scholar]
  2. Berti F., Rossoni G., Magni F., Caruso D., Omini C., Puglisi L., Galli G. Nonsteroidal antiinflammatory drugs aggravate acute myocardial ischemia in the perfused rabbit heart: a role for prostacyclin. J Cardiovasc Pharmacol. 1988 Oct;12(4):438–444. doi: 10.1097/00005344-198810000-00009. [DOI] [PubMed] [Google Scholar]
  3. Berti F., Rossoni G., Omini C., Folco G., Daffonchio L., Viganó T., Tondo C. Defibrotide, an antithrombotic substance which prevents myocardial contracture in ischemic rabbit heart. Eur J Pharmacol. 1987 Mar 31;135(3):375–382. doi: 10.1016/0014-2999(87)90687-x. [DOI] [PubMed] [Google Scholar]
  4. Bult H., Beetens J., Herman A. G. Blood levels of 6-oxo-prostaglandin F 1 alpha during endotoxin-induced hypotension in rabbits. Eur J Pharmacol. 1980 Apr 11;63(1):47–56. doi: 10.1016/0014-2999(80)90115-6. [DOI] [PubMed] [Google Scholar]
  5. Chiariello M., Golino P., Cappelli-Bigazzi M., Ambrosio G., Tritto I., Salvatore M. Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion. Am Heart J. 1988 Mar;115(3):499–504. doi: 10.1016/0002-8703(88)90796-x. [DOI] [PubMed] [Google Scholar]
  6. Dembinska-Kiec A., Kostka-Trabka E., Gryglewski R. J. Effect of prostacyclin on fibrinolytic activity in patients with arteriosclerosis obliterans. Thromb Haemost. 1982 Apr 30;47(2):190–190. [PubMed] [Google Scholar]
  7. Di Perri T., Laghi Pasini F., Capecchi P. L., Ceccatelli L., Pasqui A. L., Orrico A. Defibrotide in vitro inhibits neutrophil activation by a Ca++-involving mechanism. Int J Tissue React. 1987;9(5):399–406. [PubMed] [Google Scholar]
  8. Flores N. A., Davies R. L., Penny W. J., Sheridan D. J. Coronary microangiography in the guinea pig, rabbit and ferret. Int J Cardiol. 1984 Oct;6(4):459–471. doi: 10.1016/0167-5273(84)90326-7. [DOI] [PubMed] [Google Scholar]
  9. Friedman P. L., Brown E. J., Jr, Gunther S., Alexander R. W., Barry W. H., Mudge G. H., Jr, Grossman W. Coronary vasoconstrictor effect of indomethacin in patients with coronary-artery disease. N Engl J Med. 1981 Nov 12;305(20):1171–1175. doi: 10.1056/NEJM198111123052002. [DOI] [PubMed] [Google Scholar]
  10. Grodzińska L., König E., Schrör K. Defibrotide is equipotent to urokinase in stimulating arterial and venous thrombolysis. Pharmacol Res Commun. 1987 Sep;19(9):609–615. doi: 10.1016/0031-6989(87)90115-9. [DOI] [PubMed] [Google Scholar]
  11. Heymann M. A., Payne B. D., Hoffman J. I., Rudolph A. M. Blood flow measurements with radionuclide-labeled particles. Prog Cardiovasc Dis. 1977 Jul-Aug;20(1):55–79. doi: 10.1016/s0033-0620(77)80005-4. [DOI] [PubMed] [Google Scholar]
  12. Hinohara T., Hindman N. B., White R. D., Ideker R. E., Wagner G. S. Quantitative QRS criteria for diagnosing and sizing myocardial infarcts. Am J Cardiol. 1984 Mar 1;53(6):875–878. doi: 10.1016/0002-9149(84)90423-5. [DOI] [PubMed] [Google Scholar]
  13. Jugdutt B. I., Hutchins G. M., Bulkley B. H., Pitt B., Becker L. C. Effect of indomethacin on collateral blood flow and infarct size in the conscious dog. Circulation. 1979 Apr;59(4):734–743. doi: 10.1161/01.cir.59.4.734. [DOI] [PubMed] [Google Scholar]
  14. Kjekshus J. K., Maroko P. R., Sobel B. E. Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog. Cardiovasc Res. 1972 Sep;6(5):490–499. doi: 10.1093/cvr/6.5.490. [DOI] [PubMed] [Google Scholar]
  15. Kloner R. A., Ganote C. E., Jennings R. B. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974 Dec;54(6):1496–1508. doi: 10.1172/JCI107898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lindner V., Heinle H. Binding properties of circulating Evans blue in rabbits as determined by disc electrophoresis. Atherosclerosis. 1982 Jun;43(2-3):417–422. doi: 10.1016/0021-9150(82)90040-5. [DOI] [PubMed] [Google Scholar]
  17. Maroko P. R., Kjekshus J. K., Sobel B. E., Watanabe T., Covell J. W., Ross J., Jr, Braunwald E. Factors influencing infarct size following experimental coronary artery occlusions. Circulation. 1971 Jan;43(1):67–82. doi: 10.1161/01.cir.43.1.67. [DOI] [PubMed] [Google Scholar]
  18. Maxwell M. P., Hearse D. J., Yellon D. M. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res. 1987 Oct;21(10):737–746. doi: 10.1093/cvr/21.10.737. [DOI] [PubMed] [Google Scholar]
  19. Mullane K. M., Read N., Salmon J. A., Moncada S. Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Ther. 1984 Feb;228(2):510–522. [PubMed] [Google Scholar]
  20. NACHLAS M. M., SHNITKA T. K. Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity. Am J Pathol. 1963 Apr;42:379–405. [PMC free article] [PubMed] [Google Scholar]
  21. Niada R., Mantovani M., Prino G., Pescador R., Berti F., Omini C., Folco G. C. Antithrombotic activity of a polydeoxyribonucleotidic substance extracted from mammalian organs: a possible link with prostacyclin. Thromb Res. 1981 Aug 1;23(3):233–246. doi: 10.1016/0049-3848(81)90013-x. [DOI] [PubMed] [Google Scholar]
  22. Niada R., Porta R., Pescador R., Mantovani M., Prino G. Cardioprotective effects of defibrotide in acute myocardial ischemia in the cat. Thromb Res. 1985 Apr 1;38(1):71–81. doi: 10.1016/0049-3848(85)90008-8. [DOI] [PubMed] [Google Scholar]
  23. Ogletree M. L., Lefer A. M., Smith J. B., Nicolaou K. C. Studies on the protective effect of prostacyclin in acute myocardial ischemia. Eur J Pharmacol. 1979 Jun;56(1-2):95–103. doi: 10.1016/0014-2999(79)90438-2. [DOI] [PubMed] [Google Scholar]
  24. Pescador R., Mantovani M., Prino G., Madonna M. Pharmacokinetics of Defibrotide and of its profibrinolytic activity in the rabbit. Thromb Res. 1983 Apr 1;30(1):1–11. doi: 10.1016/0049-3848(83)90391-2. [DOI] [PubMed] [Google Scholar]
  25. Robert A. On the mechanism of cytoprotection by prostaglandins. Ann Clin Res. 1984;16(5-6):335–338. [PubMed] [Google Scholar]
  26. Romson J. L., Hook B. G., Kunkel S. L., Abrams G. D., Schork M. A., Lucchesi B. R. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation. 1983 May;67(5):1016–1023. doi: 10.1161/01.cir.67.5.1016. [DOI] [PubMed] [Google Scholar]
  27. Schrör K., Ohlendorf R., Darius H. Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia. J Pharmacol Exp Ther. 1981 Oct;219(1):243–249. [PubMed] [Google Scholar]
  28. Simpson P. J., Mitsos S. E., Ventura A., Gallagher K. P., Fantone J. C., Abrams G. D., Schork M. A., Lucchesi B. R. Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation. Am Heart J. 1987 Jan;113(1):129–137. doi: 10.1016/0002-8703(87)90020-2. [DOI] [PubMed] [Google Scholar]
  29. Smith E. F., 3rd, Gallenkämper W., Beckmann R., Thomsen T., Mannesmann G., Schrör K. Early and late administration of a PGI2-analogue, ZK 36 374 (iloprost): effects on myocardial preservation, collateral blood flow and infarct size. Cardiovasc Res. 1984 Mar;18(3):163–173. doi: 10.1093/cvr/18.3.163. [DOI] [PubMed] [Google Scholar]
  30. Smith E. F., 3rd, Kloster G., Stöcklin G., Schrör K. Effect of iloprost (ZK 36 374) on membrane integrity in ischemic rabbit hearts. Biomed Biochim Acta. 1984;43(8-9):S155–S158. [PubMed] [Google Scholar]
  31. Thiemermann C., Löbel P., Schrör K. Usefulness of defibrotide in protecting ischemic myocardium from early reperfusion damage. Am J Cardiol. 1985 Dec 1;56(15):978–982. doi: 10.1016/0002-9149(85)90416-3. [DOI] [PubMed] [Google Scholar]
  32. Utsunomiya T., Krausz M. M., Valeri C. R., Shepro D., Hechtman H. B. Treatment of pulmonary embolism with prostacyclin. Surgery. 1980 Jul;88(1):25–30. [PubMed] [Google Scholar]
  33. Vik-Mo H. Platelet accumulation in the myocardium during acute nonthrombotic coronary artery occlusion in dogs. Scand J Haematol. 1978 Sep;21(3):225–232. doi: 10.1111/j.1600-0609.1978.tb00357.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES